You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adjuvant Tamoxifen

Showing 1 - 25 of 4,949
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

Not yet recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Method(s)1 Attribution
  • Method(s)2 Attribution,
  • Colorado Springs, Colorado
    PNAF Medical
Nov 23, 2023

Breast Cancer, Breast Carcinoma, Breast Tumors Trial in Stockholm (Tamoxifen 20 mg)

Active, not recruiting
  • Breast Cancer
  • +4 more
  • Tamoxifen 20 mg
  • Stockholm, Sweden
    Karolinska University Hospital
May 24, 2022

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Jul 11, 2023

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Mar 7, 2023

Breast Cancer Trial in Beijing, Guangzhou (TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole,

Not yet recruiting
  • Breast Cancer
  • TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
  • Placebo capsules, Letrozole, Anastrozole, Tamoxifen
  • Beijing, Beijing, China
  • +1 more
Mar 10, 2023

Breast Cancer Trial in Toulouse (Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.)

Recruiting
  • Breast Cancer
  • Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
  • Toulouse, France
    Institut Universitaire du Cancer de Toulouse - Oncopole
Mar 28, 2022

Breast Cancer Trial in Norway (drug, procedure, radiation)

Active, not recruiting
  • Breast Cancer
  • Neoadjuvant tamoxifen + goserelin (premenopausal women)
  • +15 more
  • Lørenskog, Akershus, Norway
  • +6 more
Aug 24, 2021

Breast Cancer, Quality of Life Trial in Chapel Hill (Accelerated Partial Breast Irradiation (APBI), tamoxifen, anastrozole,

Recruiting
  • Breast Cancer
  • Quality of Life
  • Accelerated Partial Breast Irradiation (APBI)
  • tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene
  • Chapel Hill, North Carolina
    University of North Carolina
Jul 22, 2022

Tamoxifen in Breast Cancer and in Women at High-Risk of Breast

Active, not recruiting
  • Breast Cancer
  • +3 more
  • citalopram hydrobromide
  • +10 more
  • Indianapolis, Indiana
  • +3 more
Feb 18, 2022

Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)

Active, not recruiting
  • Breast Neoplasms
  • Perjeta Injectable Product
  • +13 more
  • Mönchengladbach, Germany
    Evangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022

Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)

Completed
  • Breast Cancer
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Nov 16, 2022

Breast Cancer Female Trial in Charlottesville, Richmond (tamoxifen, letrozole, anastrozole, or exemestane, Patient reported

Recruiting
  • Breast Cancer Female
  • tamoxifen, letrozole, anastrozole, or exemestane
  • Patient reported outcomes
  • Charlottesville, Virginia
  • +1 more
Mar 16, 2022

Breast Cancer Trial in United States (Palbociclib, Aromatase Inhibitor)

Completed
Has Results
  • Breast Cancer
  • San Francisco, California
  • +9 more
Mar 18, 2022

Breast Cancer Trial in Worldwide (Amcenestrant, Tamoxifen, Amcenestrant-matching )

Active, not recruiting
  • Breast Cancer
  • East Syracuse, New York
  • +52 more
Aug 18, 2022

Breast Cancer Trial in Italy (tamoxifen, triptorelin, letrozole)

Active, not recruiting
  • Breast Cancer
  • Avellino, AV, Italy
  • +19 more
Mar 3, 2021

HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,

Recruiting
  • HER2-positive Breast Cancer
  • +5 more
  • Pertuzumab+TRASTUZUMAB
  • ADJUVANT ENDOCRINE THERAPY
  • Stamford, Connecticut
  • +21 more
Dec 12, 2022

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

Recruiting
  • Breast Cancer
  • +2 more
    • Erlangen, Germany
      Department of Gynecology and Obstetrics, Erlangen University Hos
    May 12, 2023

    Estrogen-receptor Positive Premenopausal Early Breast Cancer

    Active, not recruiting
    • Early Breast Cancer
    • None intervention (observational study)
    • Aviano, Italy
    • +39 more
    Feb 7, 2023

    Breast Cancer Female, Hormone Receptor Positive Tumor Trial in Vancouver (Tamoxifen Citrate)

    Recruiting
    • Breast Cancer Female
    • Hormone Receptor Positive Tumor
    • Tamoxifen Citrate
    • Vancouver, British Columbia, Canada
      BC Cancer
    Dec 7, 2020

    Breast Cancer Trial in Worldwide (tamoxifen citrate, Anastrozole)

    Completed
    • Breast Cancer
    • Newcastle, Australia
    • +96 more
    Oct 5, 2021

    Breast Cancer Trial in Jakarta (Tamoxifen)

    Active, not recruiting
    • Breast Cancer
    • Jakarta, DKI Jakarta, Indonesia
      MRCCC Siloam Hospitals Semanggi
    Aug 12, 2022

    Breast Cancer Trial in Netherlands (Anastrozole)

    Unknown status
    • Breast Cancer
    • Alkmaar, Netherlands
    • +66 more
    Aug 13, 2020

    Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

    Not yet recruiting
    • Hormone-receptor-positive Breast Cancer
    • +3 more
    • Aromatase inhibitor
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Apr 5, 2023

    Breast Cancer Stage I Trial (Capecitabine,Pyrotinib)

    Not yet recruiting
    • Breast Cancer Stage I
    • (no location specified)
    May 7, 2023